Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celsion Adds Staff to Drug Development Team; Celsion appoints Dr. William Hahne as Vice President Clinical Development and Medical Affairs and Dr. Christopher Black as Executive Director, Preclinical Research.


COLUMBIA, Md. -- CELSION CORPORATION (AMEX AMEX

See: American Stock Exchange
:CLN) today announced that it had appointed William Hahne M.D., as Vice President Clinical Development and Medical Affairs and Christopher Black, Ph.D. as Executive Director, Preclinical Research.

Dr. Hahne has extensive experience in the management of clinical trial programs including oncology drug trial design and implementation. In his most recent position as Vice President, Clinical Development at Curagen Corporation, Dr. Hahne managed all clinical aspects of the company's oncology drug development program. Prior to Curagen from 1986 to 2002, he served in increasingly senior positions at Glaxo Inc., Hoechst Marion Roussel and Eisai Inc., Dr. Hahne earned his M.D. at Cornell University Medical School.

Dr. Black who was a John E. Fogarty John Edward Fogarty (March 23 1913 - January 10 1967) was a Congressman from Rhode Island for 26 years.

He was born in Providence, Rhode Island. His brother, Charles Fogarty, Sr., was a State Senator and Director of the Rhode Island Small Business Administration.
 Fellow and Associate at the National Institutes of Health and a lecturer at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.  earned his Ph.D. at the University of London For most practical purposes, ranging from admission of students to negotiating funding from the government, the 19 constituent colleges are treated as individual universities. Within the university federation they are known as Recognised Bodies  in the United Kingdom and has led preclinical development groups at companies such as Protarga, Nycomed Amersham and Sterling Winthrop Imaging. He has extensive experience in the development of anticancer therapeutics and diagnostics, as well as the development of liposomal based drug carrier systems.

Dr. Lawrence Olanoff, Celsion's Chief Executive Officer, commented, "I am delighted that Bill and Chris have joined our team. Their research and development experience will be invaluable as we continue to build a portfolio of oncology products. Drs. Hahne and Black have extensive oncology experience which will contribute substantially to our progress as we focus entirely on oncology drug development. We remain committed to building a portfolio of oncology applications by using our heat activated drug delivery technology as a platform and thus create greater shareholder value."

ABOUT CELSION: Celsion Corporation, based in Columbia, Maryland, is a biotechnology company dedicated to the development and commercialization of heat activated treatment systems for cancer.

Celsion has research, license or commercialization agreements with leading institutions such as the National Institute of Health, Duke University Medical Center, Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , Harbor UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. , Montefiore Medical Center Montefiore Medical Center, in the Bronx, New York, is the university hospital of the Albert Einstein College of Medicine. The hospital, named after Moses Montefiore, is one of the 50 largest employers in New York State [1].  and Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New  in New York City, Roswell Park Cancer Institute The Roswell Park Cancer Institute is a cancer research and treatment center located in Buffalo, New York. Founded in 1898 by Dr. Roswell Park, it was the first dedicated medical facility for cancer treatment and research in the United States.  in Buffalo, New York, and Duke University. For more information on Celsion, visit our website: www.celsion.com.

Celsion wishes to inform readers that forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. In addition, Celsion's receipt of the royalty payments in connection with the sale of Celsion (Canada) depends upon the ability of Celsion (Canada) to develop the APA technology and bring products to market. This involves, among other risks of a new enterprise, financing, regulatory and market acceptance risks.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:Celsion Adds Staff to Drug Development Team; Celsion appoints Dr.
Publication:Business Wire
Geographic Code:1USA
Date:Jan 19, 2006
Words:506
Previous Article:MBIA Capital/Claymore Managed Duration Investment Grade Municipal Fund Announces Results of Annual Meeting of Shareholders.
Next Article:American Healthways Announces Three New Hospital Agreements.
Topics:



Related Articles
Celsion Corporation Announces Award of Option Grant to Dr. Lawrence Olanoff.
Celsion Corporation to Present at the NYSSA 9th Annual Biotech/Specialty Pharma Conference.
Celsion Sells Breast Cancer Treatment Subsidiary to Former CEO in Transaction Valued at up to $20 Million.
Celsion Corporation Reports Good Progress in Its Cancer Drug Development Business.
ThermoDox(TM) Animal Studies to be Presented at 6th International Symposium on Therapeutic Ultrasound in Oxford, England.
Celsion Corporation Announces New President/CEO.
New Study Reports Preclinical Findings Involving Celsion Heat Activated Liposome.
Celsion Reports on ThermoDox(TM) at American Society of Clinical Oncology Gastrointestinal Symposium.
Celsion Expands Board, Appoints New Independent Director.
Celsion Files for Special Protocol Assessment for ThermoDox in combination with Radiofrequency Ablation for treatment of Non-Resectable...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles